These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 18479052)

  • 1. [Construction of an infectious clone of equine infectious anemia virus by N-glycosylation reverse-mutations].
    Han X; Quan Y; Gao X; Xiang W; Zhou J
    Wei Sheng Wu Xue Bao; 2008 Mar; 48(3):287-92. PubMed ID: 18479052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Construction and in vitro evaluation of an infectious clone of the equine infectious anemia virus vaccine strain EIAV(FDDV) with four reverse-mutated vaccine-specific sites in the S2 gene].
    Gao X; Jiang CG; Han XE; Zhao LP; Shen RX; Xiang WH; Zhou JH
    Bing Du Xue Bao; 2009 Jul; 25(4):309-15. PubMed ID: 19769166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence.
    Shen T; Liang H; Tong X; Fan X; He X; Ma Y; Xiang W; Shen R; Zhang X; Shao Y
    Vaccine; 2006 Feb; 24(6):738-49. PubMed ID: 16202485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV.
    Liang H; He X; Shen RX; Shen T; Tong X; Ma Y; Xiang WH; Zhang XY; Shao YM
    Arch Virol; 2006 Jul; 151(7):1387-403. PubMed ID: 16502285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.
    Han X; Zou J; Wang X; Guo W; Huo G; Shen R; Xiang W
    Viral Immunol; 2010 Oct; 23(5):531-9. PubMed ID: 20883167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the long terminal repeat from a cytopathic strain of equine infectious anemia virus.
    Madden CR; Shih DS
    Virology; 1996 Nov; 225(2):395-9. PubMed ID: 8918926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
    Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
    Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein.
    Cook RF; Berger SL; Rushlow KE; McManus JM; Cook SJ; Harrold S; Raabe ML; Montelaro RC; Issel CJ
    J Virol; 1995 Mar; 69(3):1493-9. PubMed ID: 7853482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.
    Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Kong X; Zhou J
    Arch Virol; 2011 Feb; 156(2):353-7. PubMed ID: 21136127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.
    Han X; Zhang P; Yu W; Xiang W; Li X
    Virus Genes; 2016 Dec; 52(6):814-822. PubMed ID: 27572122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and mutational analysis of the reverse transcriptase of the lentivirus equine infectious anemia virus.
    Shaharabany M; Rice NR; Hizi A
    Biochem Biophys Res Commun; 1993 Oct; 196(2):914-20. PubMed ID: 7694581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A replication competent lentivirus (RCL) assay for equine infectious anaemia virus (EIAV)-based lentiviral vectors.
    Miskin J; Chipchase D; Rohll J; Beard G; Wardell T; Angell D; Roehl H; Jolly D; Kingsman S; Mitrophanous K
    Gene Ther; 2006 Feb; 13(3):196-205. PubMed ID: 16208418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection of bone marrow macrophages by equine infectious anemia virus.
    Swardson CJ; Lichtenstein DL; Wang S; Montelaro RC; Kociba GJ
    Am J Vet Res; 1997 Dec; 58(12):1402-7. PubMed ID: 9401688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equine infectious anemia virus derived from a molecular clone persistently infects horses.
    Whetter L; Archambault D; Perry S; Gazit A; Coggins L; Yaniv A; Clabough D; Dahlberg J; Fuller F; Tronick S
    J Virol; 1990 Dec; 64(12):5750-6. PubMed ID: 2173767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies.
    Fagerness AJ; Flaherty MT; Perry ST; Jia B; Payne SL; Fuller FJ
    Virology; 2006 May; 349(1):22-30. PubMed ID: 16503341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
    Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-terminal truncation of the transmembrane protein of an attenuated lentiviral vaccine alters its in vitro but not in vivo replication and weakens its potential pathogenicity.
    Jiang CG; Gao X; Ma J; Lin YZ; Wang XF; Zhao LP; Hua YP; Liu D; Zhou JH
    Virus Res; 2011 Jun; 158(1-2):235-45. PubMed ID: 21539871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain.
    Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K
    Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and immunogenicity of equine infectious anemia virus membrane protein GP90].
    Dai CB; Xiao Y; Lu H; Shen RX; Shao YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):73-6. PubMed ID: 12870025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of inducible EIAV-based lentiviral vector packaging and producer cell lines.
    Stewart HJ; Leroux-Carlucci MA; Sion CJ; Mitrophanous KA; Radcliffe PA
    Gene Ther; 2009 Jun; 16(6):805-14. PubMed ID: 19262613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.